Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer
- PMID: 18823035
- DOI: 10.1002/cncr.23849
Neoadjuvant gemcitabine and cisplatin: another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer
Comment on
-
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.Cancer. 2008 Nov 1;113(9):2471-7. doi: 10.1002/cncr.23848. Cancer. 2008. PMID: 18823036 Free PMC article.
Similar articles
-
Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".Int J Urol. 2024 Oct;31(10):1107. doi: 10.1111/iju.15537. Epub 2024 Jul 16. Int J Urol. 2024. PMID: 39010790 No abstract available.
-
Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".Int J Urol. 2024 Oct;31(10):1106. doi: 10.1111/iju.15541. Epub 2024 Jul 16. Int J Urol. 2024. PMID: 39010787 No abstract available.
-
Pathological responses to gemcitabine/platinum-based neoadjuvant chemotherapy for muscle-invasive urothelial cancer.Asia Pac J Clin Oncol. 2012 Mar;8(1):101-2. doi: 10.1111/j.1743-7563.2011.01465.x. Epub 2012 Feb 20. Asia Pac J Clin Oncol. 2012. PMID: 22369451 No abstract available.
-
[Modern chemotherapy of invasive bladder cancer].Magy Onkol. 2007;51(2):133-8. Epub 2007 Jul 29. Magy Onkol. 2007. PMID: 17660869 Review. Hungarian.
-
Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.Clin Genitourin Cancer. 2016 Feb;14(1):e103-5. doi: 10.1016/j.clgc.2015.08.009. Epub 2015 Sep 3. Clin Genitourin Cancer. 2016. PMID: 26431887 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical